News

Interim analysis from ongoing Phase I/II clinical trial with DC vaccines in AML patients presented at EHA

SHOW RELEASE

Medigene AG reports on Annual General Meeting 2019

SHOW RELEASE

Medigene announces clinical trial agreement for HA-1 TCR immunotherapy MDG1021 with University of Leiden

SHOW RELEASE

Medigene to present interim data analysis from Phase I/II DC-Vaccine trial at the EHA conference 2019

SHOW RELEASE

Medigene reports financial & business results for the first three months of 2019

SHOW RELEASE

bluebird presents preclinical data of first TCR candidate from Medigene collaboration. Start clinical development 2020

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Medigene presented data on favorable safety pattern of PRAME-specific TCR on neuronal cells at 2019 ASGCT Meeting

SHOW RELEASE

Medigene sells remaining rights and inventories of VeregenĀ® to Aresus Pharma

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia

SHOW RELEASE

Medigene presented selective killing of tumor cells by PRAME TCR-transduced T cells at AACR

SHOW RELEASE

Medigene publishes 2018 Annual Report

SHOW RELEASE

Medigene presented paths to potential neoantigen-based TCR-therapies

SHOW RELEASE

Medigene publishes preliminary financial results for the financial year 2018

SHOW RELEASE